VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery

VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery Statistically and clinically...

TraceLink Announces Grant Recipients Driving Impact Across the Globe

TraceLink Announces Grant Recipients Driving Impact Across the Globe

BOSTON, Dec. 3, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has announced the recipients of its 2024 corporate grant program. The grants have been awarded to five...

Cellid Announces "Reference Design," its Proprietary Lightweight, AR Smart Glasses

Cellid Announces "Reference Design," its Proprietary Lightweight, AR Smart Glasses

Begins recruiting development partners for key use cases OEM partners aiming to develop their own AR glasses TOKYO, Dec. 3, 2024 /PRNewswire/ -- Cellid Inc., a developer of AR glasses displays and spatial recognition engines for next-generation...

Williams Lea bolsters leadership and growth focus with two executive committee appointments

Williams Lea bolsters leadership and growth focus with two executive committee appointments

NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Global tech-enabled business support services firm Williams Lea announces the appointment of Hillary McNally as Chief Revenue Officer (CRO) and Alastair Kelly as Managing Director, Asia Pacific. These...

Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow

Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow

Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA...

Uxin Announces Strategic Partnership with CATL's Subsidiary to Develop Battery Swapping Ecosystem for Used Cars

Uxin Announces Strategic Partnership with CATL's Subsidiary to Develop Battery Swapping Ecosystem for Used Cars

BEIJING, Dec. 3, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced a strategic partnership with Times Electric Service, a wholly-owned subsidiary of Contemporary Amperex...

Speeki Carbon Lens® revolutionises GHG emissions accounting

Speeki Carbon Lens® revolutionises GHG emissions accounting

SINGAPORE and LONDON, Dec. 3, 2024 /PRNewswire/ -- Speeki, a global leader in ESG and sustainability management and reporting, announces the release of Carbon Lens®: an AI-powered complete carbon management solution within Speeki's sustainability...

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures – SOMERSET, N.J., Dec. 3, 2024 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce...

Ridgewood Infrastructure Announces Acquisition of Valley Cold

Ridgewood Infrastructure Announces Acquisition of Valley Cold

NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Ridgewood Infrastructure, a leading investment firm focused on essential infrastructure in the U.S. lower middle market, today announced its investment in Valley Cold Storage & Transportation ("Valley...

Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index

Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index

HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company's Ordinary Shares, which trade on The Stock Exchange of Hong Kong Limited...

  • 1
  • ...
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • ...
  • 48
  • menu
    menu